Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Sinusoidal communication in chronic liver disease

Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho

Clin Mol Hepatol. 2025;31(1):32-55. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0734

View: 1734 Download: 222 Web of Science: 1 Crossref: 1

Snapshot

Immunopathogenesis of liver fibrosis in steatotic liver disease

Chaerin Woo, Won-Il Jeong

Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0113

View: 3464 Download: 122

Correspondence

Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances

Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu

Clin Mol Hepatol. 2024;30(2):279-280. Published online March 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0191

View: 2644 Download: 69 Web of Science: 1 Crossref: 1

Original Article

JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis

Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Yan, Jia Ding, Xiao Teng, Qiang Yang, Xiu-Ping Liu, Jian Wu

Clin Mol Hepatol. 2024;30(2):206-224. Published online January 8, 2024

DOI: https://doi.org/10.3350/cmh.2023.0506

View: 5532 Download: 255 Web of Science: 5 Crossref: 5

Editorial

JCAD, a new potential therapeutic target in cholestatic liver disease

Byoung Kuk Jang

Clin Mol Hepatol. 2024;30(2):166-167. Published online March 8, 2024

DOI: https://doi.org/10.3350/cmh.2024.0128

View: 2959 Download: 78 Web of Science: 1 Crossref: 1

Original Article

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions

Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun

Clin Mol Hepatol. 2023;29(2):465-481. Published online February 20, 2023

DOI: https://doi.org/10.3350/cmh.2022.0327

View: 7327 Download: 312 Web of Science: 17 Crossref: 20

Review

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clin Mol Hepatol. 2021;27(3):413-424. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0187

View: 15741 Download: 506 Web of Science: 30 Crossref: 32

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0037

View: 9115 Download: 241 Web of Science: 15 Crossref: 15

Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 13377 Download: 250 Web of Science: 79 Crossref: 85

NADPH oxidase mediated oxidative stress in hepatic fibrogenesis

Yong-Han Paik, David A. Brenner

Clin Mol Hepatol. 2011;17(4):251-257. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.251

View: 10422 Download: 79 Crossref: 40

Hemodynamic alterations in cirrhosis and portal hypertension

Moon Young Kim, Soon Koo Baik, Samuel S. Lee

Clin Mol Hepatol. 2010;16(4):347-352. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.347

View: 12164 Download: 175 Crossref: 69

3

Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB

HyeWon Shin, M.S., Soo Young Park, M.S., Kyoung Bun Lee, M.D., Eun Shin, M.D., Suk Woo Nam, Ph.D. Jung Young Lee, M.D. Ja-June Jang, M.D.

Clin Mol Hepatol. 2009;15(4):486-495. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.486

View: 5219 Download: 55 Crossref: 3

2

The Role of Activated Hepatic Stellate Cells in Liver Fibrosis, Portal Hypertension and Cancer Angiogenesis

June Sung Lee , Jong Hoon Kim

Clin Mol Hepatol. 2007;13(3):309-319. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.309

View: 5607 Download: 61 Crossref: 12

7

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37: 87-95

Geun Youn Gwok , Jung Hwan Yoon

Clin Mol Hepatol. 2003;9(2):145-146. Published online January 1, 1970

View: 2636 Download: 18

3

The Expression of E - cadherin in Human and Rat Hepatic Stellate Cells / Evidence of Epithelial - Mesenchymal Transition

Young Suk Lim,Hyo Suk Lee

Clin Mol Hepatol. 2002;8(1):90-99. Published online January 1, 1970

View: 2716 Download: 23

Protective Effect of Pentoxifylline and Ciprofloxacin on Dimethylnitrosamine-induced Hepatic Fibrosis in Rats

Kang Suek Suh,Chang Hun Lee,Mee Young Sol,Sun Kyung Lee

Clin Mol Hepatol. 2001;7(1):34-46. Published online January 1, 2000

View: 2543 Download: 19

1 |

Viewed By 6971	MAFLD: How is it different from NAFLD?
Viewed By 6218	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5315	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5147	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4664	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 266	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 170	MAFLD: How is it different from NAFLD?
Cited By 92	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search